Miriannette Gayoso1, Whei Ying Lim1, Madhuri S Mulekar2, Anne-Marie D Kaulfers3. 1. Department of Pediatrics, University of South Alabama, Strada Patient Care Center, 1601 Center St, Suite 1 S, Mobile, AL, 36604, USA. 2. Department of Mathematics and Statistics, University of South Alabama, 411 N University Blvd North, Mobile, AL, 36688, USA. 3. Department of Pediatrics, University of South Alabama, Strada Patient Care Center, 1601 Center St, Suite 1 S, Mobile, AL, 36604, USA. akaulfers@health.southalabama.edu.
Abstract
BACKGROUND: With the onset of the COVID-19 pandemic and state-mandated school closures in the spring of 2020, the management of type 1 diabetes in children underwent significant changes. The aim of our study was to assess the effect of stay-at-home orders on glycemic control in children. METHODS: We conducted a retrospective review of 238 children with type 1 and type 2 diabetes who were seen in the Pediatric Endocrinology Clinic at the University of South Alabama. Average Hemoglobin A1c (A1c) levels in the year prior to stay-at home orders (May 2019-April 2020) were compared with A1c values during the quarantine period (May 2020-July 2020) using a paired t-test. We also analyzed the change of A1c level with respect to sex, race, type of diabetes, type of insurance, and mode of insulin administration, using a 2-sample t-test. RESULTS: The average A1c significantly increased from 9.2% during the previous year to 9.5% during the quarantine period (p = 0.0097). The increase of A1c was significantly higher in public insurance patients (0.49% increase) compared to private insurance patients (0.03% increase), (p = 0.0137). We also observed a significant association between the direction of change and type of insurance. Forty-eight percent of public insurance patients had an A1c increase of > 0.5% while 54% of private insurance patients had no change or decrease in A1c (p = 0.0079). CONCLUSIONS: The COVID-19 pandemic resulted in worsening glycemic control in children with type 1 diabetes, with those on public insurance affected in greater proportion than those with private insurance.
BACKGROUND: With the onset of the COVID-19 pandemic and state-mandated school closures in the spring of 2020, the management of type 1 diabetes in children underwent significant changes. The aim of our study was to assess the effect of stay-at-home orders on glycemic control in children. METHODS: We conducted a retrospective review of 238 children with type 1 and type 2 diabetes who were seen in the Pediatric Endocrinology Clinic at the University of South Alabama. Average Hemoglobin A1c (A1c) levels in the year prior to stay-at home orders (May 2019-April 2020) were compared with A1c values during the quarantine period (May 2020-July 2020) using a paired t-test. We also analyzed the change of A1c level with respect to sex, race, type of diabetes, type of insurance, and mode of insulin administration, using a 2-sample t-test. RESULTS: The average A1c significantly increased from 9.2% during the previous year to 9.5% during the quarantine period (p = 0.0097). The increase of A1c was significantly higher in public insurance patients (0.49% increase) compared to private insurance patients (0.03% increase), (p = 0.0137). We also observed a significant association between the direction of change and type of insurance. Forty-eight percent of public insurance patients had an A1c increase of > 0.5% while 54% of private insurance patients had no change or decrease in A1c (p = 0.0079). CONCLUSIONS: The COVID-19 pandemic resulted in worsening glycemic control in children with type 1 diabetes, with those on public insurance affected in greater proportion than those with private insurance.
Entities:
Keywords:
COVID-19 quarantine; Diabetes; School nurse
Authors: Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane Journal: Diabetes Care Date: 2015-06 Impact factor: 19.112
Authors: Maria Jose Redondo; Ingrid Libman; Peiyao Cheng; Craig Kollman; Mustafa Tosur; Robin L Gal; Fida Bacha; Georgeanna J Klingensmith; Mark Clements Journal: Diabetes Care Date: 2018-03-01 Impact factor: 19.112
Authors: Jessica M Valenzuela; Michael Seid; Beth Waitzfelder; Andrea M Anderson; Daniel P Beavers; Dana M Dabelea; Lawrence M Dolan; Giuseppina Imperatore; Santica Marcovina; Kristi Reynolds; Joyce Yi-Frazier; Elizabeth J Mayer-Davis Journal: J Pediatr Date: 2014-02-25 Impact factor: 4.406